Exploration of the Relationship Between Mismatch Repair Status of Colorectal Cancer and Lymph Node Metastasis Patterns and Pathological High-risk Factors
NCT06798857 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1471
Last updated 2025-12-02
Summary
This study analyzed the differences in clinical baseline features and survival outcomes between pMMR and dMMR patients. The aim is to evaluate the impact of MMR status on overall survival and disease-free survival of colorectal patients, and to explore the population exempt from extended resection, so as to provide evidence-based medical evidence for the relationship between MMR status, lymph node metastasis pattern and clinicopathological risk factors in colon cancer patients.
Conditions
Sponsors & Collaborators
-
Sixth Affiliated Hospital, Sun Yat-sen University
lead OTHER
Principal Investigators
-
Zerong Cai, MD · Sixth Affiliated Hospital, Sun Yat-sen University
Eligibility
- Min Age
- 20 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-14
- Primary Completion
- 2021-09-07
- Completion
- 2024-09-09
More Related Trials
-
Early Lymph Node Metastasis in T1/2 Stage Colorectal Cancer: Molecular and Clinical Insights
NCT06130644 ·Status: COMPLETED
-
Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status
NCT05610592 ·Status: COMPLETED
-
Extent of Lymph Node Dissection for Advanced Right-Sided Colon Cance
NCT06986538 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing
NCT03561350 ·Status: UNKNOWN
-
Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer
NCT06293612 ·Status: COMPLETED
-
Genomic Signatures for Patients With Initially Unresectable Colorectal Liver Metastases
NCT06477718 ·Status: COMPLETED
-
The Molecular Mechanism of RAS Wild-type mCRC Resistance to Anti-EGFR-antibody
NCT04466267 ·Status: COMPLETED
-
The CSTME Associates With the Prognosis of Stage II and III Colorectal Cancer
NCT05420415 ·Status: COMPLETED
-
Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer
NCT06849362 ·Status: ENROLLING_BY_INVITATION
-
Deep Learning-Based Analysis of Colorectal Cancer Pathology Images: An Innovative Approach for Predicting Colorectal Cancer Subtypes
NCT06936098 ·Status: COMPLETED
-
Comparison of Expression of Carcinogenesis-related Molecular Markers in the Patients With Colon Cancer and Polyp
NCT05638542 ·Status: ACTIVE_NOT_RECRUITING
-
Estimating Lymphocyte Counts from DNA Methylation
NCT06586307 ·Status: COMPLETED
-
Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal Cancer
NCT06883084 ·Status: ENROLLING_BY_INVITATION
-
MRI Features in Neoadjuvant Treatment Decisions for Patients With Rectal Cancer
NCT05609149 ·Status: COMPLETED
-
Prognosis Stratification for pT4bN0M0 Colorectal Cancer Following Multivisceral Resection
NCT06115837 ·Status: COMPLETED
-
Mechanism and Process Regulation for Colorectal Tumors
NCT04707482 ·Status: UNKNOWN
-
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey
NCT01549067 ·Status: UNKNOWN
-
Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis
NCT02979795 ·Status: UNKNOWN
-
Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients
NCT03829852 ·Status: COMPLETED
-
PET on Surgery for Loco-regionally Recurrent Colorectal Cancer
NCT05924282 ·Status: COMPLETED
-
Predicting Rectal Adenoma With Canceration and Investigating Mechanism Based on Multimodal MRI and Biochemical Model
NCT06158776 ·Status: COMPLETED
-
Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM
NCT05485909 ·Status: UNKNOWN ·Phase: PHASE2
-
Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
NCT07154173 ·Status: RECRUITING
-
Clinical Significance of Marginal Acute Inflammation for Stage II Colon Cancer
NCT06135558 ·Status: COMPLETED
-
Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial
NCT07279077 ·Status: RECRUITING ·Phase: PHASE2